Metabolic syndrome: clinical and angiographic impact on patients with acute coronary syndrome

• Published in: Cirugia y cirujanos Vol. 78; no. 2; p. 113
• Main Authors: Miller, Alejandra Madrid, Alcaraz Ruiz, Antonio, Borrayo Sánchez, Gabriela, Almeida Gutiérrez, Eduardo, Vargas Guzmán, Rosa María, Jáuregui Aguilar, Ricardo
• Format: Journal Article
• Language: English
• Published: Mexico 01-03-2010
• Subjects: Acute Coronary Syndrome - complications; Coronary Angiography; Coronary Artery Disease - diagnostic imaging; Coronary Artery Disease - epidemiology; Coronary Artery Disease - etiology; Female; Humans; Male; Metabolic Syndrome - complications; Middle Aged
• ISSN: 2444-054X

Metabolic syndrome (MetS) is represented by a cluster of various risk factors and is one of the most important public health problems of the 21st century. The aim of this study was to identify the impact of this syndrome in patients with acute coronary syndrome (ACS).
We included patients with ST and non-ST segment elevation ACS. We divided patients into two groups: A) patients with MetS criteria and B) patients without MetS criteria. We compared the incidence of major cardiovascular events, severity of coronary artery disease (CAD), need for urgent revascularization and in-hospital mortality between groups.
Among 917 patients with ACS, 421 (43.4%) fulfilled criteria of MetS. Age of patients in this group was 63.37 +/- 9.95 years (compared with 61.77 +/- 12.20 years in group B), 66.7% vs. 72.8% males, diabetes 70.3% vs. 33.3%, hypertension 87.6% vs. 40.5% and dyslipidemia 70.5% vs. 26.9%, respectively. ST-elevation ACS was more frequent in group A. We observed more severe CAD, and major cardiovascular events were more frequent in group A. Multivariate analysis demonstrated that hyperfibrinogenemia, hyperglycemia and MetS were independent predictors of heart failure and combined end point.
Incidence of MetS was high in patients with ACS, presented with more comorbidities and older patients, and was associated with poorer in-hospital outcome. It may be probable that the high inflammatory and prothrombotic response and more severe CAD in these patients increase the incidence of major cardiovascular events.